DiaMonTech GmbH, a start-up company specializing in non-invasive blood glucose measurement methods, took part in the "Innovation trifft Politik" forum. At the series of events, which took place at the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), the company introduced itself to Federal Secretary of Health Jens Spahn, among others. The aim of the conference was to exploit the opportunities offered by digitisation in the health sector more effectively. DiaMonTech was one of four companies selected by a jury to present their digital health services for the treatment of chronic diseases.
Founded in Berlin, Germany, in 2015, DiaMonTech is a medical technology company committed to improving health outcomes for people with diabetes and empowering them to take control of their lifelong health. Its pioneered and patented non-invasive “no prick” photothermal detection technology is fast and painless and doesn’t require needles or test strips. An industry first, DiaMonTech monitors the actual glucose molecules in skin, providing users with a more comprehensive and accurate reading comparable to invasive commercial devices. DiaMonTech achieved 99.1% accuracy in a test study with 100 people studied, received the CE mark as a medical device in April 2019 and is currently under FDA review. To support its mission, DiaMonTech is led by a world-class team of scientists, researchers and healthcare experts.
More information about DiaMonTech can be found at www.diamontech.de.